A possible case of carbamazepine-induced renal phospholipidosis mimicking Fabry disease | Clinical and Experimental Nephrology
Fabry Disease Associated With Antiglomerular Basement Membrane Disease: Chance or Consequence - Kidney International Reports
Aortopathies in mouse models of Pompe, Fabry and Mucopolysaccharidosis IIIB lysosomal storage diseases | PLOS ONE
Patterns
Lysosomal storage disease - Wikipedia
Evolution of cardiac pathology in classic Fabry disease: Progressive cardiomyocyte enlargement leads to increased cell death and fibrosis, and correlates with severity of ventricular hypertrophy - ScienceDirect
Medullary thick ascending limb impairment in the GlatmTg(CAG‐A4GALT) Fabry model mice - Maruyama - 2018 - The FASEB Journal - Wiley Online Library
Anderson-Fabry Disease and Other Lysosomal Storage Disorders | Circulation
Imbalanced Production of Reactive Oxygen Species and Mitochondrial Antioxidant SOD2 in Fabry Disease-Specific Human Induced Pluripotent Stem Cell-Differentiated Vascular Endothelial Cells - Wei-Lien Tseng, Shih-Jie Chou, Huai-Chih Chiang, Mong-Lien ...
JCM | Free Full-Text | Downregulation of Mannose-6-Phosphate Receptors in Fabry Disease Cardiomyopathy: A Potential Target for Enzyme Therapy Enhancement
IJMS | Free Full-Text | α-Galactosidase a Deficiency in Fabry Disease Leads to Extensive Dysregulated Cellular Signaling Pathways in Human Podocytes
Fabry & Myelinosomes | Art of Medicine | Arkana Laboratories
Periodic acid Schiff (PAS) staining. Periodic acid Schiff (PAS) stained... | Download Scientific Diagram
Periodic Acid-Schiff (PAS) Staining
Cardiac Microvascular Pathology in Fabry Disease | Circulation
Fabry disease associated with multiple myeloma: a case report | CEN Case Reports
Reduced α-galactosidase A activity in zebrafish (Danio rerio) mirrors distinct features of Fabry nephropathy phenotype - ScienceDirect
Fabry's Disease: Case Series and Review of Literature
Frontiers | Vacuolated PAS-Positive Lymphocytes on Blood Smear: An Easy Screening Tool and a Possible Biomarker for Monitoring Therapeutic Responses in Late Onset Pompe Disease (LOPD)
Evidence-Based Management of Patients with Fabry Disease | National Kidney Foundation
Anderson-Fabry Disease and Other Lysosomal Storage Disorders | Circulation
